Skip to search formSkip to main contentSkip to account menu

activin A

Known as: EYDF, erythroid differentiation factor, A-activin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Objective To investigate the efficacy of P-glycoprotein monoclonal antibody in the treatment of MRL/lpr mice. Methods… 
2014
2014
OBJECTIVE To investigate the expression and significance of follistatin, activin A and bone morphogenetic protein-4 (BMP-4) in… 
2009
2009
Purpose: The most important consideration for therapy using MSCs is the differentiation of the target organ’s cell type. For in… 
2004
2004
To the Editor: Activin A is a newly recognized pluripotent growth factor1. In a recent issue of Kidney International, we reported… 
2003
2003
From the ‡Department of Medicine, Metabolism and Endocrinology and the ¶Atopy Research Center School of Medicine, Juntendo… 
2000
2000
N-myc oncogene amplification is frequent in human neuroblastoma and predicts poor prognosis, but the molecular consequences have… 
1998
1998
Inhibin was originally described as the active principle or substance in the testis which was able to prevent the appearance of… 
1993
1993
This study was undertaken to assess the role of protein kinase C (PKC) in activin action in the rat pituitary. Pretreatment with…